搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Thermoplasma acidophilum Probable tRNA pseudouridine synthase D (truD) CSB-YP881093TND
CSB-EP881093TND
CSB-BP881093TND
CSB-MP881093TND
CSB-EP881093TND-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermoplasma acidophilum Ribose-phosphate pyrophosphokinase (prs) CSB-YP881094TND
CSB-EP881094TND
CSB-BP881094TND
CSB-MP881094TND
CSB-EP881094TND-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermoplasma acidophilum UPF0095 protein Ta0097 (Ta0097) CSB-YP881095TND
CSB-EP881095TND
CSB-BP881095TND
CSB-MP881095TND
CSB-EP881095TND-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermoplasma acidophilum Probable cobyric acid synthase (cobQ) CSB-YP881096TND
CSB-EP881096TND
CSB-BP881096TND
CSB-MP881096TND
CSB-EP881096TND-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermoplasma acidophilum DNA-binding protein Ta0052 (Ta0052) CSB-YP881097TND
CSB-EP881097TND
CSB-BP881097TND
CSB-MP881097TND
CSB-EP881097TND-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermoplasma acidophilum Probable N-glycosylase/DNA lyase (ogg) CSB-YP881098TND
CSB-EP881098TND
CSB-BP881098TND
CSB-MP881098TND
CSB-EP881098TND-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermoplasma acidophilum V-type ATP synthase subunit E (atpE) CSB-YP881099TND
CSB-EP881099TND
CSB-BP881099TND
CSB-MP881099TND
CSB-EP881099TND-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halobacterium salinarum RNA-binding protein AU-1 (aubA) CSB-YP881100HTM
CSB-EP881100HTM
CSB-BP881100HTM
CSB-MP881100HTM
CSB-EP881100HTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halobacterium salinarum F420-0:gamma-glutamyl ligase (cofE) CSB-YP881101HTM
CSB-EP881101HTM
CSB-BP881101HTM
CSB-MP881101HTM
CSB-EP881101HTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halobacterium salinarum Phenylalanine--tRNA ligase beta subunit (pheT), partial CSB-YP881102HTM
CSB-EP881102HTM
CSB-BP881102HTM
CSB-MP881102HTM
CSB-EP881102HTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halobacterium salinarum UPF0200 protein VNG_2452C (VNG_2452C) CSB-YP881103HTM
CSB-EP881103HTM
CSB-BP881103HTM
CSB-MP881103HTM
CSB-EP881103HTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halobacterium salinarum UvrABC system protein B (uvrB), partial CSB-YP881104HTM
CSB-EP881104HTM
CSB-BP881104HTM
CSB-MP881104HTM
CSB-EP881104HTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halobacterium salinarum 1- (5-phosphoribosyl)-5-[ (5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase (hisA) CSB-YP881105HTM
CSB-EP881105HTM
CSB-BP881105HTM
CSB-MP881105HTM
CSB-EP881105HTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halobacterium salinarum Ribosomal RNA large subunit methyltransferase E (rlmE) CSB-YP881106HTM
CSB-EP881106HTM
CSB-BP881106HTM
CSB-MP881106HTM
CSB-EP881106HTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halobacterium salinarum 5-methylthioadenosine/S-adenosylhomocysteine deaminase (mtaD) CSB-YP881107HTM
CSB-EP881107HTM
CSB-BP881107HTM
CSB-MP881107HTM
CSB-EP881107HTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halobacterium salinarum Dihydrolipoyl dehydrogenase (lpdA) CSB-YP881108HTM
CSB-EP881108HTM
CSB-BP881108HTM
CSB-MP881108HTM
CSB-EP881108HTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halobacterium salinarum Isoleucine--tRNA ligase (ileS), partial CSB-YP881109HTM
CSB-EP881109HTM
CSB-BP881109HTM
CSB-MP881109HTM
CSB-EP881109HTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halobacterium salinarum V-type ATP synthase subunit D (atpD) CSB-YP881110HTM
CSB-EP881110HTM
CSB-BP881110HTM
CSB-MP881110HTM
CSB-EP881110HTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halobacterium salinarum Imidazole glycerol phosphate synthase subunit HisH (hisH) CSB-YP881111HTM
CSB-EP881111HTM
CSB-BP881111HTM
CSB-MP881111HTM
CSB-EP881111HTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Halobacterium salinarum Proteasome-activating nucleotidase 2 (pan2) CSB-YP881112HTM
CSB-EP881112HTM
CSB-BP881112HTM
CSB-MP881112HTM
CSB-EP881112HTM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>